FridayNov 18, 2022 3:42 pm

QualityStocksNewsBreaks – GeoSolar Technologies Inc.’s SmartGreen(TM) Is Total Building Energy ‘Makeover’

GeoSolar Technologies is a Colorado-based company dedicated to Net-Zero initiatives by helping residents and businesses reduce carbon emissions and achieve energy independence. “The company’s SmartGreen(TM) Home systems harness the power of the sun and earth to heat and cool buildings, charge electric vehicles, and run electric appliances while purifying the air and maximizing energy efficiency… With an eye on global Net-Zero goals, GeoSolar’s technology empowers building owners to act locally by leveraging a mix of renewable energy sources. The company’s patent pending SmartGreen(TM) Home system is a total building energy ‘makeover’ that comprises solar panels and geothermal ground loops to…

Continue Reading

FridayNov 18, 2022 3:01 pm

QualityStocksNewsBreaks – REZYFi Inc. Leading Industry with Diversified Approach to Real Estate Lending Sector

REZYFi, a growth mortgage origination and specialized financing company servicing the needs of both traditional and non-traditional consumers and businesses, is uniquely positioned as the first cannabis mortgage banker in the United States. “REZYFi operates through two wholly owned subsidiaries – REZYFi Lending and ResMac, Inc. REZYFi Lending leverages a wide network to offer options such as 15- to 30-year fixed-rate, FHA, VA, and jumbo loans and reverse and adjustable-rate mortgages. The company expects increased funding in marketing and loan agents to drive significant origination growth over the next two years, further supported by the company’s launch of a high-margin…

Continue Reading

FridayNov 18, 2022 12:29 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Potential Hypertension Treatment Poised to Provide Reprieve to Millions of Patients

Lexaria Bioscience Corp. (NASDAQ: LEXX) is developing a potential hypertension treatment with little to no side effects. “The treatment is created by processing cannabidiol (‘CBD’) using the company’s patented DehydraTECH(TM) drug delivery technology, which has been shown to substantially increase the bioavailability of active pharmaceutical ingredients (‘APIs’). In human studies, Lexaria has shown that DehydraTECH-CBD not only increases the amount of CBD in the blood by as much as 317% but also reduces blood pressure and arterial stiffness,” a recent article reads. “Lexaria hopes to prove, through registered clinical trials, that its DehydraTECH-CBD formulation has an acceptable safety and tolerability…

Continue Reading

FridayNov 18, 2022 11:58 am

QualityStocksNewsBreaks – Sharing Services Global Corporation (SHRG) Promoting Health, Wealth and Happiness; Capturing Market Share

Sharing Services (OTCQB: SHRG), a company dedicated to maximizing shareholder value, is guided by clear vision, mission and values in its commitment to promote health, wealth and happiness by reshaping how entrepreneurs succeed today. “The company notes that ‘the quality of internal decisions determines the quality and success of outcomes. Emotional decision making can often tilt the decision-making objectives. Adherence to guiding principles and values serve all in arriving at the most effective and collaborative decision.’ The company states its guiding principles and values as follows: we exist to serve people; technology must always be a strength; less is more;…

Continue Reading

FridayNov 18, 2022 11:15 am

DGE’s 2nd Advancing Diversity Equity & Inclusion In Pharma & Healthcare Summit

DE&I leaders, executives, and professionals from the pharma, biotech, healthcare, and allied industries, are invited to the 2nd Advancing Diversity Equity & Inclusion (“ADEI”) In Pharma and Healthcare Summit. This online live-streaming event will be held on December 8-9, 2022. The agenda will guide you to move from awareness towards advocacy and action, as you build a culture of representation and inclusion for success in the workplace and clinical trial management. Professionals and industry experts from the medical realm gather on this forum to discuss and explore ways to attain success and improve the patient’s overall experience. This live-streaming event…

Continue Reading

FridayNov 18, 2022 10:38 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Placement Funding

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has entered into a securities purchase agreement with two healthcare-focused institutional investors. The agreement outlines plans for the issuance and sale of 1,818,185 of INM common shares; the shares will be issued at a purchase price of $3.30 per share or prefunded warrant. In addition, the agreement notes that INM will issue unregistered preferred investment options to the same investors; those options include purchasing up to 3,272,733 additional common shares. According to the announcement, the company anticipates the private placement, which…

Continue Reading

FridayNov 18, 2022 10:30 am

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Modular Green Ammonia System Represents Needed and Timely Solution to Global Food and Energy Resilience

FuelPositive Corp. is a Canadian developer of clean energy solutions, focusing on an on-site system for producing hydrogen-dense green ammonia The company’s modular system can produce 300 kg per day (500 liters per day) of liquid anhydrous carbon-free ammonia — the amount needed to fertilize a 2,000-acre farm The system’s ability to grant end users greater energy independence as a climate-friendly resource is filling a market need at an opportune time as industries struggle to manage supply chain challenges created by COVID and the ongoing Russia-Ukraine war The module is being tested in a pilot project by Canadian farmers and…

Continue Reading

FridayNov 18, 2022 10:14 am

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) CEO Discusses Next-Level Technology on Stock Day Podcast

Mullen Automotive (NASDAQ: MULN), a Southern California-based company building the next generation of premium electric vehicles (“EVs”) that are affordable and built entirely in the U.S., was featured on a recent episode of the Stock Day Podcast. Mullen’s CEO David Michery joined Stock Day host Everett Jolly to discuss the company’s milestones, partnerships, strategic acquisitions, deliverables, and the successful debut of Mullen’s first electric crossover. The EV crossover, for which the company is currently accepting pre-orders and expected to arrive on the market in 2024, was recently recognized for its design and state-of-the-art PERSONA technology. “The response has been overwhelming,”…

Continue Reading

FridayNov 18, 2022 10:00 am

QualityStocksNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Announces Preliminary Fiscal 2022 Revenues, Expected 201% YOY Increase

Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of gaming platforms, systems and gaming content, today announced its preliminary revenues for the fiscal year ending Oct. 31, 2022, reflecting expected record revenues of more than $34 million. According to the update, this represents an estimated 201% improvement on revenues of $11.3 million in the comparable twelve-month period ending Oct. 31, 2021. Golden Matrix acquired its 80% controlling interest in RKingsCompetitions Ltd (“Rkings”), which operates a business-to-consumer (“B2C”) tournament platform, at the beginning of the fiscal year. As a result, there were no contributions by Rkings to GMGI’s overall revenues…

Continue Reading

FridayNov 18, 2022 9:45 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Head of Technical R&D Presents Flagship NanoAbs Platform at Recent RAFT Conference

The presentation focused on BiondVax’s yeast fermentation system to manufacture innovative alpaca-derived recombinant nanosized VHH-antibodies (NanoAbs) and highlighted the company’s NanoAbs as a platform for development of therapeutics addressing diseases with large unmet medical needs and attractive commercial opportunities BiondVax’s lead NanoAb candidate, an inhaled COVID-19 treatment, exhibits significant competitive advantages over currently available mAbs and oral COVID-19 therapies Development of additional NanoAbs, targeting psoriasis, asthma, psoriatic arthritis and wet macular degeneration is underway via a strategic collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Gottingen (“UMG”), both in Germany BiondVax Pharmaceuticals (NASDAQ: BVXV),…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered